So if the DSMC says the drug is not working and “recommends” stopping the trial at mid point, Cytodyn could say nope it’s our trial we set it up and we are going to keep going even though you “recommend” we stop. Similarly, if the DSMC “recommended” you “modify” your trial (the very people who are instrumental in approval of your drug) you would say nope, no modifications we are going to do it our way. How about the last option, DSMC says don’t make any changes, you think the company would say forget those guys let’s add two more shots for next 14 days. Doesn’t fly, the DSMC DOES run the trial wether you believe it or not. For the DSMC to see the results after 14 days and not modify trial by adding 2 more shots for let’s say half of the trial group was just stupid. Very, very puzzling....
Market Data 
Markets 
AI
